JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB265823

Human SLC38A9 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

SLC38A9 KO cell line available to order. KO validated. Free of charge wild type control available. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and 5 bp deletion in exon 3. To order both knockout and wild-type control cells: select '2 x 1000000 Cells/vial'. To order only knockout cells: select '1000000 Cells/vial'.

View Alternative Names

Up-regulated in lung cancer 11, Solute carrier family 38 member 9, SLC38A9, Neutral amino acid transporter 9, URLC11

2 Images
Sanger Sequencing - Human SLC38A9 knockout HeLa cell line (AB265823)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC38A9 knockout HeLa cell line (AB265823)

Allele-2 : 1 bp insertion in exon 3.

Sanger Sequencing - Human SLC38A9 knockout HeLa cell line (AB265823)
  • Sanger seq

Unknown

Sanger Sequencing - Human SLC38A9 knockout HeLa cell line (AB265823)

Allele-1 : 5 bp deletion in exon 3.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon 3 and 5 bp deletion in exon 3

Disease

Adenocarcinoma

Product details

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265823-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265823 Human SLC38A9 knockout HeLa cell line", "number":"AB265823-CMP01" }, { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265823-CMP02" } ] }, "2x1000000Cellsvial": { "sellingSize": "2 x 1000000 Cells/vial", "publicAssetCode":"ab265823-2x1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab255928 Human wild-type HeLa cell line", "number":"AB265823-CMP02" }, { "size":"1 x 1000000 Cells/vial", "name":"ab265823 Human SLC38A9 knockout HeLa cell line", "number":"AB265823-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265823-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265823 Human SLC38A9 knockout HeLa cell line", "number":"AB265823-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab265823-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab265823 Human SLC38A9 knockout HeLa cell line", "number":"AB265823-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
SLC38A9
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SLC38A9 also known as SNAT9 functions as an amino acid transporter and sensor within lysosomes. It specifically mediates the transport of essential amino acids and related signals from the lysosomal lumen to the cytoplasm. The protein has a mass of approximately 61 kilodaltons and is primarily expressed in tissues with high metabolic activity like the liver kidneys and brain. This expression pattern supports its role in cellular and metabolic homeostasis.
Biological function summary

This protein serves as a component of the mechanistic target of rapamycin complex 1 (mTORC1) signaling pathway. SLC38A9 directly interacts with the lysosomal surface to connect amino acid availability to mTORC1 activation. By doing so it influences cell growth and autophagy processes in response to amino acid levels. As a part of the mTORC1 complex SLC38A9 plays an important function in translating extracellular cues to intracellular responses.

Pathways

SLC38A9 is integral in the amino acid sensing mechanism that regulates the mTORC1 pathway. This pathway controls vital processes like protein synthesis and cell proliferation. The protein partners with other key players in the mTOR signaling pathway including Rag GTPases and Raptor to relay amino acid abundance to the mTORC1 complex. This relationship ensures that cellular growth processes are synchronized with available nutrition resources.

SLC38A9 is implicated in metabolic diseases and cancer. Dysregulation of amino acid sensing and mTORC1 activity mediated through SLC38A9 contributes to metabolic disorders such as obesity and type 2 diabetes. Moreover its involvement with mTORC1 links it to cancer progression as mTORC1 is often upregulated in tumors. This relationship suggests a potential therapeutic interest in targeting SLC38A9 together with proteins like mTOR for disease intervention.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability. <p>1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.<br>2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.<br>3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.<br>4. Incubate the culture at 37°C incubator with 5% CO<sub>2</sub>. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.<br>5. Once confluent passage into an appropriate flask at a density of 2x10<sup>4</sup> cells/cm<sup>2</sup>. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.</p>

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com